Dr. Axe Wire · Food, herbs & supplements · health

Amino Acid L-Arginine Blocks Inflammation Switch In Mouse Studies

A common amino acid appears to calm a key inflammation trigger tied to arthritis and Parkinson's symptoms in mouse models.

By Dr. Axe Editorial Team · October 19, 2026 · 1 source · Watch

A study published October 6, 2026 in Nature Metabolism reports that the amino acid L-arginine directly blocks a key inflammation switch in the body, easing arthritis and brain inflammation in mouse models.

Researchers report that L-arginine, a common amino acid found in protein-rich foods, binds directly to a specific site (called Asp31) on the NLRP3 protein, a central switch in inflammatory signaling. This binding blocked the protein from connecting with its partner molecule ASC, preventing the inflammasome from assembling and activating in mouse immune cells grown in the lab. Adding L-arginine suppressed this activation; withholding it increased activation. In mice, L-arginine treatment eased arthritis caused by uric acid crystals and eased inflammation in an aluminum-induced peritonitis model. In separate mouse models of Parkinson's disease, L-arginine supplementation reduced brain inflammation and improved movement problems, while depriving mice of L-arginine made the disease worse. In blood samples from people with Parkinson's disease, L-arginine levels were lower than controls.

The NLRP3 inflammasome is a protein complex inside immune cells that, once assembled, triggers a cascade of inflammatory signaling tied to arthritis, gout flares and neurodegenerative disease. The authors describe L-arginine as working upstream, physically blocking assembly of this complex rather than just calming inflammation after it starts. The authors frame L-arginine supplementation as a potential therapeutic avenue for NLRP3-driven conditions.

Our study establishes L-Arg supplementation as a promising therapeutic avenue for managing NLRP3-driven inflammatory pathologies.

Study authorsNature Metabolism, 2026

This is animal and cell research: every disease experiment was in mice, and the abstract does not report sample sizes. The human finding is a blood-level comparison in Parkinson's patients, not a supplementation trial, so it cannot show whether raising arginine intake changes disease outcomes in people.

Dr. Axe’s Take

L-arginine is an amino acid most people get every day from food, and this study suggests it does more than support blood flow. In mice, it blocked a key inflammation switch called NLRP3 and eased arthritis, peritonitis and Parkinson's-like symptoms, and people with Parkinson's had lower blood levels. That is mouse data plus one blood comparison, not proof a supplement treats anything in people. I'd start with food: pumpkin seeds, turkey, chickpeas, lentils and spirulina are solid sources. If you're managing Parkinson's or gout, keep your current treatment and ask your doctor before adding an arginine supplement.

— Dr. Axe

Take the Cellular Health Quiz →

Story summary

Who: Mice with crystal-induced arthritis, peritonitis or Parkinson's disease models; blood from Parkinson's patients; sample sizes not reported
Design: Lab and mouse study plus a human blood comparison
Dose: Not reported
Primary result: L-Arg bound NLRP3 at the Asp31 site, blocking assembly with ASC and inflammasome activation in macrophages
Secondary: In mice, eased arthritis, peritonitis, and Parkinson's-model neuroinflammation and motor deficits; Parkinson's patients had lower serum L-Arg
Funding / conflicts: Funders listed in the journal record: National Natural Science Foundation of China; Future Scholar Program of Shandong University; National Key Research and Development Program. Conflict statement in the PubMed record: The authors declare no competing interests.
Date: Oct 6, 2026